Results 191 to 200 of about 113,882 (274)

Development and evaluation of novel zein-based artemisinin sustained-release formulation for treating drug-resistant malaria. [PDF]

mBio
Wang Y, Yu X, Zhang X, He X, Tang Y, Fang L, Culleton R, Zhang Q, Dong W, Cao J.   +9 more
europepmc   +1 more source

Evaluation of the Diagnostic Accuracy of the Quantitative Point‐of‐Care SD Biosensor Standard G6PD Test for Assessment of G6PD Deficiency in Infectious Diseases

International Journal of Laboratory Hematology, Volume 48, Issue 2, Page 440-446, April 2026.
ABSTRACT Background G6PD deficiency affects about 500 million people worldwide and is prevalent in many malaria‐endemic settings. People with G6PD deficiency are at risk of hemolysis when exposed to certain medications, including 8‐aminoquinoline drugs used to treat Plasmodium vivax malaria.
Flavia Regina Medeiros da Silva, Alexandre Gomes Vizzoni, Daniela Mendes‐de‐Almeida, Joanna Bokel, Raquel de Vasconcellos Carvalhaes de Oliveira, André Machado Siqueira, Yasmine Rangel Vieira, Simone da Costa Cruz Silva   +7 more
wiley   +1 more source

Allicin-based biomimetic nanoparticles of the erythrocyte membrane for the delivery of lumefantrine to enhance its antimalarial effect. [PDF]

Int J Pharm X
Yu C, Li X, Cai K, Jiang W, Chen W, Xia R, Xu M, Feng J, Ling C, Zhou S, Chen Y, Zeng F, Xu Q, He X, Li M, Song J, Liang J.   +16 more
europepmc   +1 more source

Plastid Engineering for Photosynthesis‐Driven Synthesis of Hyaluronic Acid in Tobacco

Plant Biotechnology Journal, Volume 24, Issue 4, Page 2541-2558, April 2026.
ABSTRACT Hyaluronic acid (HA) is a glycosaminoglycan composed of alternating units of N‐acetylglucosamine and glucuronic acid. High moisture retention, viscoelasticity and biocompatibility are unique features that make HA polymers attractive compounds for medical applications and aesthetic purposes.
Amanda Lopes, Omar Sandoval‐Ibáñez, Stéphanie Arrivault, David Rolo, F. Vanessa Loiacono, Alexander Erban, Daniel Karcher, Stephan Obst, Stephanie Ruf, Joachim Kopka, Ralph Bock   +10 more
wiley   +1 more source

LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity. [PDF]

PLoS Pathog
He X, Zhang Y, Lou J, Wu J, Xu S, Zhu G, Tang J, Fang Y, Cao J.   +8 more
europepmc   +1 more source

The Global Landscape of <i>Plasmodium falciparum</i> Drug Resistance Markers, 2005-2025: A Systematic Review and Meta-Analysis. [PDF]

Pathogens
Habarugira F, Batamuriza J, Ndahimana R, Minega JN, Dieng MM, Mutsaka-Makuvaza MJ, Daba TM, Idaghdour Y, Mutesa L.   +8 more
europepmc   +1 more source

Reevaluating malaria severity metrics: insights from PfHRP2-derived biomass estimates in Ghanaian children. [PDF]

Malar J
Konadu EA, Obese AO, Danso-Coffie CK, Addison T, Kyei-Baafour E, Obiri D, Amoah LE, Kusi KA, Gyan B, Oduro D.   +9 more
europepmc   +1 more source

Accessibility to antimalarials in Spanish hospitals: analysis of a national survey. [PDF]

Malar J
Bretones-Pedrinaci JI, Castro-Vida MA, Urda-Romacho J, Lozano-Serrano AB, Salas-Coronas J.   +4 more
europepmc   +1 more source